Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with ad-vanced melanoma treated with nivolumab / Capone, M; Giannarelli, D; Mallardo, D; Madonna, G; Festino, L; Grimaldi, Am; Vanella, V; Si-meone, E; Paone, M; Palmieri, G; Cavalcanti, E; Caracò, C; Ascierto, Pa. - In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. - ISSN 2051-1426. - 16:(2018). [10.1186/s40425-018-0383-1]
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with ad-vanced melanoma treated with nivolumab
Palmieri GInvestigation
;
2018-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
